138 related articles for article (PubMed ID: 22593454)
41. Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.
Della Pepa C; Tonini G; Santini D; Losito S; Pisano C; Di Napoli M; Cecere SC; Gargiulo P; Pignata S
Cancer Treat Rev; 2015 Feb; 41(2):136-43. PubMed ID: 25573350
[TBL] [Abstract][Full Text] [Related]
42. Total pelvic exenteration for pelvic recurrence after advanced epithelial ovarian cancer--A case report and literature review.
Bacalbașa N; Bălescu I
J Med Life; 2015; 8(3):263-5. PubMed ID: 26351524
[TBL] [Abstract][Full Text] [Related]
43. [Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer].
Mu T; Li XP; Wang JL; Wang SJ; Wang Y; Sun XL; Cui H; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):566-70. PubMed ID: 23141174
[TBL] [Abstract][Full Text] [Related]
44. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
45. Amelanotic malignant melanoma of the uterine cervix diagnosed by cervical smear.
Arık D; Öge T; Kabukçuoğlu S; Yalçın ÖT; Özalp S
Diagn Cytopathol; 2016 Jun; 44(6):535-7. PubMed ID: 26991516
[TBL] [Abstract][Full Text] [Related]
46. Polarized light dermoscopy to aid in the diagnosis of new pink lesions in an amelanotic melanoma survivor.
Cymerman RM; Penn L; Meehan S; Polsky D
J Am Acad Dermatol; 2015 Dec; 73(6):e197-9. PubMed ID: 26568348
[No Abstract] [Full Text] [Related]
47. Primary amelanotic mucosal melanoma of the oronasal region: report of two new cases and literature review.
Paulo LF; Servato JP; Rosa RR; Oliveira MT; Faria PR; Silva SJ; Cardoso SV; Loyola AM
Oral Maxillofac Surg; 2015 Dec; 19(4):333-9. PubMed ID: 25934245
[TBL] [Abstract][Full Text] [Related]
48. [A case of amelanotic melanoma of the nasal cavity].
Shibata H; Yamane T; Hashimoto S; Terada Y; Takubo T; Hino M; Tatsumi N; Inoue T; Kamitani T
Rinsho Byori; 2002 Jul; 50(7):712-6. PubMed ID: 12187711
[TBL] [Abstract][Full Text] [Related]
49. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
[TBL] [Abstract][Full Text] [Related]
50. Epithelial ovarian cancer.
Ng JS; Low JJ; Ilancheran A
Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):337-45. PubMed ID: 22281513
[TBL] [Abstract][Full Text] [Related]
51. Amelanotic conjunctival melanoma.
Bongiorno MR; Lodato G; Affronti A; Aragona F; Aricò M
Cutis; 2006 Jun; 77(6):377-81. PubMed ID: 16838771
[TBL] [Abstract][Full Text] [Related]
52. [The amelanotic melanoma of the rectum].
Borger M; Golz R; Prohm P
Chirurg; 2002 Dec; 73(12):1215-7. PubMed ID: 12491051
[TBL] [Abstract][Full Text] [Related]
53. Preoperative CA-125 Value as a Predictive Factor for Postoperative Outcome in First Relapse of Platinum-sensitive Serous Ovarian Cancer.
Parashkevova A; Sehouli J; Richter R; Dimitrova D; Braicu EI; Muallem MZ
Anticancer Res; 2018 Aug; 38(8):4865-4870. PubMed ID: 30061261
[TBL] [Abstract][Full Text] [Related]
54. [Significance of hepatic resection in the treatment of hepatic parenchymal metastasis of recurrent epithelial ovarian carcinoma].
Yan X; Bao Q; An N; Gao YN; Jiang GQ; Gao M; Zheng H; Wang W
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):132-7. PubMed ID: 21575484
[TBL] [Abstract][Full Text] [Related]
55. Primary Vaginal Melanoma, A Rare and Aggressive Entity. A Case Report and Review of the Literature.
Kalampokas E; Kalampokas T; Damaskos C
In Vivo; 2017 Jan; 31(1):133-139. PubMed ID: 28064232
[TBL] [Abstract][Full Text] [Related]
56. Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer.
Fujiwara K; McAlpine JN; Lheureux S; Matsumura N; Oza AM
Am Soc Clin Oncol Educ Book; 2016; 35():e247-57. PubMed ID: 27249730
[TBL] [Abstract][Full Text] [Related]
57. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.
Nguyen TM; Shin IW; Lee TJ; Park J; Kim JH; Park MS; Lee EJ
Gynecol Oncol; 2016 Mar; 140(3):545-53. PubMed ID: 26691219
[TBL] [Abstract][Full Text] [Related]
58. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
[TBL] [Abstract][Full Text] [Related]
59. Intracranial amelanotic melanoma: a case report with literature review.
Ma J; Zhang Z; Li S; Chen X; Wang S
World J Surg Oncol; 2015 May; 13():182. PubMed ID: 25963017
[TBL] [Abstract][Full Text] [Related]
60. Immunophenotyping of amelanotic melanoma. A case report.
Lazarević V; Tiodorović J; Tiodorović-Zivković D; Stanojević M; Popović D; Janković A
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Sep; 15(3):141-3. PubMed ID: 17053850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
